Author

Ann E. Walts

Cedars-Sinai Medical CenterORCID 0000-0002-6893-5748Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Sandra OršulićiD· 3 shared Beth Y. KarlaniD· 2 shared Alexander M. XuiD· 1 shared Alexandra Smick· 1 shared Amanda J. CompadreiD· 1 shared Andrea R. HagemanniD· 1 shared Angela M. SchabiD· 1 shared Arkadiusz GertychiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Sandra OršulićORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 28, 2026

Spatially resolved transcriptional programs link fallopian tube precursor lesions to immune activation and stromal reorganization

María Sol Recouvreux, Kathleen Trang, Alexandra Smick…·Sandra Oršulić

This study uses spatial transcriptomics to analyze fallopian tube lesions and identifies immune and stromal changes associated with early ovarian cancer development.

DOI 10.64898/2026.08.27.747392

humanspatial transcriptomics

𝕏 PostBluesky

Cancer BiologyScientific ReportsPeer-reviewedDec 6, 2025

Combined inhibition of NAD synthesis and C-terminal binding protein cooperatively induce cell death and inhibit growth of High Grade Serous Ovarian Carcinoma

Kranthi Kumar Chougoni, Jacqueline L. West, Nicholette St. Martin…·Steven R. Grossman

The paper shows that combining CtBP inhibitors with NAD synthesis inhibitors enhances cell death and inhibits growth of high-grade serous ovarian carcinoma.

DOI 10.1038/s41598-025-30990-7

humanproteomics

𝕏 PostBluesky

Cancer BiologyJournal of Clinical InvestigationPeer-reviewedMay 20, 2025

Replication stress marker phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination-proficient ovarian cancer

Angela M. Schab, Amanda J. Compadre, Rikki Drexler…·Mary Margaret Mullen

This study identifies phospho-RPA2 as a biomarker predicting response to platinum and PARP inhibitors in HR-proficient ovarian cancer, showing higher pathologic complete response and longer survival in pRPA2-High tumors.

11 citationstop 5%

humanimaging

𝕏 PostBluesky